MIN XIN HOLD (00222) issued a profit warning, expecting the mid-term profit attributable to shareholders to be approximately HKD 32.5 million to HKD 37.5 million, a year-on-year decrease of about 42% to 50%.
Minxin Group (00222) announced that the Group expects to record a prospective attributable profit to shareholders of approximately HKD 32.5 million to HKD 37.5 million for the six months ending June 30, 2026, representing a decrease of approximately 42% to 50% compared to the same period in 2025.
MIN XIN HOLD (00222) announced that the group expects to record a profit attributable to shareholders of approximately HKD 32.5 million to HKD 37.5 million for the six months ending June 30, 2026, representing a decrease of about 42% to 50% compared to the same period in 2025.
Related Articles

US Stock Market Move | Merck & Co., Inc. (MRK.US) and Moderna (MRNA.US) both saw their stock prices soar! The phase III trial of the personalized mRNA cancer vaccine was successful.

CONTINENTAL H (00513) plans to sell all shares of IQ Group for HKD 85 million, resuming trading on August 20.

Jiangsu Hengrui Pharmaceuticals (01276): Liu Xiaohan resigns as joint company secretary.
US Stock Market Move | Merck & Co., Inc. (MRK.US) and Moderna (MRNA.US) both saw their stock prices soar! The phase III trial of the personalized mRNA cancer vaccine was successful.

CONTINENTAL H (00513) plans to sell all shares of IQ Group for HKD 85 million, resuming trading on August 20.

Jiangsu Hengrui Pharmaceuticals (01276): Liu Xiaohan resigns as joint company secretary.

RECOMMEND





